Strategic health economic support
throughout the product journey.
We provide expert insights and support
from pipeline to patients.
Our collaborative partnership helps to optimize each opportunity:
We take a broad look at the opportunities for a given treatment and identify a value story. We find insightful answers to the question: "What is the true value of this product?"
We tailor our analyses for each target audience: providers, payers, policy makers, or the wider scientific community.
The Medicus Approach
Whether we are developing novel analyses and models, or providing strategic guidance to our clients, each Medicus engagement is highly customized to solve cutting edge problems at the intersection of healthcare, evidence, and value.
We help build the value story and communicate with decision makers throughout the product journey.
We combine analytical expertise with industry knowledge to provide tailored solutions for our clients.See Examples
Our team has the know-how and experience to tackle any challenge. Our flexible, individualized approach provides responsive support from a diverse group of health economics and market access experts.Get to know us
Our research has been published in peer-reviewed journals and presented at industry conferences across a wide spectrum of disease areas.
Gene therapies present lifelong cures for patients but novel reimbursement challenges for payers. We balanced methodological rigor with a creative approach to support the first-ever approved gene therapy.
Reimbursement restrictions can provide short-term savings for payers but have unintended and negative consequences for patients. Using real-world data, we showed the harmful effects of copay accumulator adjustment programs on specialty drug adherence.
Patient support programs aim to help patients adhere to prescribed treatment; however, their benefits to patients and providers have not been quantified. We conducted studies to demonstrate short- and long-term benefits of patient support programs to patients and payers.